Decreased Pain and Improved Quality of Life in Fibromyalgia Patients Treated with Olanzapine, an Atypical Neuroleptic

作者: Robert N. Freedenfeld , Michelle Murray , Perry N. Fuchs , R. Sanford Kiser

DOI: 10.1111/J.1533-2500.2006.00072.X

关键词:

摘要: Fibromyalgia is a significant clinical problem associated with generalized pain and interference daily activities. Although variety of treatment modalities have been utilized, clinicians struggled to find an effective means treatment. Therefore, this study assessed the efficacy atypical neuroleptic olanzapine for fibromyalgia symptoms. To examine symptoms, charts 51 patients treated were evaluated improvements in life functioning. At time initial assessment, had diagnosed medical psychiatric disorders history Pain was widespread characteristic fibromyalgia. Pretreatment ratings on scales averaged 6.54-8.69 0-10 scale. Post-treatment same revealed improvement virtually all scales. The benefits improve symptoms must, however, be carefully considered because there side effects (i.e., weight gain, somnolence/sedation) that sufficient strength cause number discontinue In general, data provide strong support can, certain patients, who limited success other modalities.

参考文章(33)
Carol S. Burckhardt, Sharon R. Clark, Connie A. O'Reilly, Robert M. Bennett, Arthur N. Wiens, Stephen M. Campbell, Group treatment of fibromyalgia: a 6 month outpatient program. The Journal of Rheumatology. ,vol. 23, pp. 521- 528 ,(1996)
Thomas W. Bohr, Fibromyalgia syndrome and myofascial pain syndrome. Do they exist Neurologic Clinics. ,vol. 13, pp. 365- 384 ,(1995) , 10.1016/S0733-8619(18)30051-3
Frank P Bymaster, Julie F Falcone, Delbert Bauzon, John S Kennedy, Kathryn Schenck, Neil W DeLapp, Marlene L Cohen, Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine European Journal of Pharmacology. ,vol. 430, pp. 341- 349 ,(2001) , 10.1016/S0014-2999(01)01399-1
Scott W Woods, Alan Breier, Robert B Zipursky, Diana O Perkins, Jean Addington, Tandy J Miller, Keith A Hawkins, Eva Marquez, Stacy R Lindborg, Mauricio Tohen, Thomas H McGlashan, Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome Biological Psychiatry. ,vol. 54, pp. 453- 464 ,(2003) , 10.1016/S0006-3223(03)00321-4
H. Wolf, Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists Scandinavian Journal of Rheumatology. ,vol. 29, pp. 37- 45 ,(2000) , 10.1080/030097400446625
Frank P Bymaster, David O Calligaro, Julie F Falcone, Richard D Marsh, Nicholas A Moore, Nicholas C Tye, Philip Seeman, David T Wong, Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology. ,vol. 14, pp. 87- 96 ,(1996) , 10.1016/0893-133X(94)00129-N
Natalia Khojainova, Juan Santiago-Palma, Craig Kornick, William Breitbart, Gilbert R. Gonzales, Olanzapine in the management of cancer pain. Journal of Pain and Symptom Management. ,vol. 23, pp. 346- 350 ,(2002) , 10.1016/S0885-3924(02)00378-0